GlaxoSmithKline Consumer Nigeria Overview

  • Founded
  • 1971

Founded
  • Status
  • Public

  • Employees
  • 64

Employees
  • Stock Symbol
  • GLAXOSMITH

Stock Symbol
  • Share Price
  • $0.01

  • (As of Friday Closing)

GlaxoSmithKline Consumer Nigeria General Information

Description

GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures innovative pharmaceutical medicines, vaccines, and consumer healthcare products. The company has two reportable segments, Consumer Healthcare segment consisting of oral care, over-the-counter (OTC) medicines and nutritional healthcare; and Pharmaceuticals segment consisting of vaccines and prescription drugs. The company's product line includes panadol, Andrews liver salt, Macleans, ampiclox, Sensodyne, Horlicks, and others. It generates maximum revenue from the Pharmaceuticals segment.

Contact Information

Website
www.ng.gsk.com
Ownership Status
Publicly Held
Financing Status
Corporation
Primary Industry
Pharmaceuticals
Stock Exchange
NSA
Primary Office
  • GSK House, 1, Industrial Avenue
  • Ilupeju
  • Lagos, 100252
  • Nigeria

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

GlaxoSmithKline Consumer Nigeria Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.01 $0.01 $0.01 - $0.02 $16.6M 1.2B 519K

GlaxoSmithKline Consumer Nigeria Financials Summary

In Thousands,
USD
TTM 31-Dec-2021 FY 2021 31-Dec-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
EV (2,952) (2,952) 2,662 11,904
Revenue 54,534 54,534 55,525 56,972
EBITDA 3,136 3,136 3,775 3,547
Net Income 1,600 1,600 1,622 2,517
Total Assets 63,449 63,449 59,755 50,919
Total Debt 4 4 296 599
Public Fundamental Data provided by Morningstar, Inc. disclaimer

GlaxoSmithKline Consumer Nigeria Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
GlaxoSmithKline Consumer Nigeria PLC is a healthcare company that researches, develops, and manufactures innovative phar
Pharmaceuticals
Lagos, Nigeria
64 As of 2021

000000

it, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
000000000000000
Staines-Upon-Thames, United Kingdom
0000 As of 0000
00.00
0000000000.

00000

lit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, qui
000000000000000
Ahmedabad, India
00000 As of 0000
000.00
0000 0000-00-00
00000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

GlaxoSmithKline Consumer Nigeria Competitors (8)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Mallinckrodt Corporation Staines-Upon-Thames, United Kingdom 0000 00.00 0000000000.
00000 000000000000 Corporation Ahmedabad, India 00000 000.00 00000000 000.00
00. 00000'0 000000 Corporation Hyderabad, India 00000 00000 00000000000 00000
0000 0000000000000 Corporate Backed or Acquired Petach Tikva, Israel 00000 00000 00000000000 00000
00000 Corporation Mumbai, India 00000 00000000
You’re viewing 5 of 8 competitors. Get the full list »

GlaxoSmithKline Consumer Nigeria Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial